In Brief: Wisconsin Pharmacal/Chartex correction
This article was originally published in The Gray Sheet
Executive Summary
Wisconsin Pharmacal/Chartex correction: Wisconsin Pharmacal Company's acquisition of Chartex ("The Gray Sheet" Dec. 4, I&W-8) does not resolve the issue of data referenced by Chartex in its premarket approval application for the female condom, WPC says. WPC and Family Health International continue to question FDA's decision to allow Chartex to reference FHI data in its PMA...